Development and Therapeutic Uses of Topical 5% Idoxuridine (IDU)

Burnett J. W. Katz S. L. (1963). Study of the use of 5-iodo2¹-deoxyuridine in cutaneous Herpes simplex. Journal of Investigative Dermatology, 40, 7

Corbett M. B. Sidell C. M. Zimmerman M. (1966). Idoxuridine in the treatment of cutaneous Herpes simplex. Journal of the American Medical Association, 196, 441

Dawber R. P. R. (1973). Idoxuridine in Herpes simplex followed by erythema multiforme. British Medical Journal, 1, 737

Dawber R. P. R. (1974). Idoxuridine in Herpes zoster: further evaluation of intermittent topical therapy. British Medical Journal, 11, 526

Dawber R. P. R. (1977). Chemotherapy for varicella-zoster infections. British Medical Journal, 1, 286

Goldman L. Mitzmiller K. W. (1965). Topical 5 iodo-2¹-deoxyuridine in dimethyl sulphoxide (D.M. S.O.): new treatment for severe herpes simplex. Ohio State Medical Journal, 61, 532

Hall-Smith S. P. Corrigan M. J. Gilkes M. J. (1962). Treatment of herpes simplex with idoxuridine. British Medical Journal, 11, 1515

Herrman E. C. Jr. (1961). Plaque inhibition test for detection of specific inhibitors of DNA-containing viruses. Proceedings of the Society of Experimental Biology and Medicine (N.Y.), 107, 142

Hucker H. B. Miller J. K. Hochberg A. Brobyn F. H. Riordan F. H. Catesnick B. (1967). Studies of absorption, excretion and metabolism of deiethyl sulphoxide (D.M.S.O.) in man. Journal of Pharmacology and Experimental Therapeutics, 155, 309

Jacob S. W. Herschier R. (1975). Biological actions of dimethyl sulphoxide. Annals of the New York Academy of Sciences, 243, 5

Juel-Jensen B. E. MacCallum F. O. (1964). Treatment of herpes simplex lesions of the face with idoxuridine: results of double-blind controlled trial. British Medical Journal, 11, 987

Juel-Jensen B. E. MacCallum F. O. (1965). Herpes simplex lesions of the face treated with idoxuridine applied by spray gun: results of double-blind controlled trial. British Medical Journal, 1, 901

Juel-Jensen B. E. MacCallum F. O. (1972). Herpes simplex, varicella and zoster, p. 123, 1st Edition. London: Heinemann

Kaplan A. S. (1969). Herpes simplex and pseudo-rabies. 1st Edition. New York: Springer-Verlag, Wren

Kaufman H. E. (1962). Clinical cure of herpes simplex keratitis by 5-iodo-2¹-deoxyuridine. Proceedings of the Society of Experimental Biology and Medicine (New York), 102, 251

Kligman A. M. (1965). Topical pharmacology and toxicology of dimethyl sulphoxide. Journal of the American Medical Association, 193, 923

Leake C. D. (1967). Biological actions of dimethyl sulphoxide. Annals of the New York Academy of Sciences, 141, 1

MacCallum F. O. Juel-Jensen B. E. (1966). Herpes simplex virus skin infection in man treated with idoxuridine in dimethyl sulphoxide: results of double-blind controlled trial. British Medical Journal, 11, 805

Osmundsen P. E. (1975). Allergic contact dermatitis from idoxuridine. Contact Dermatitis 1, 251

Parker J. D. J. (1975). Genital herpes. British Journal of Sexual Medicine, 2, 9

Prusoff W. H. (1959). Synthesis and biological activities of idoxuridine, an analogue of thymidine. Biochimica et Biophysica Acta, 32, 295

Rapp F. Vanderslice D. (1964). Spread of zoster virus in human embryonic lung cells and the inhibitory effect of iodo-deoxyuridine. Virology, 22, 321

Simpson J. R. (1975). Idoxuridine in the treatment of herpes zoster. Practitioner, 215, 226

Welch A. D. Prusoff W. H. (1960). A synopsis of recent investigations of 5-iodo-2¹-deoxyuridine. Cancer Chemotherapy Reports, p. 29